Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-alcoholic fatty liver disease in lean individuals
Somaya Albhaisi, Abhijit Chowdhury, Arun J. Sanyal
JHEP Reports (2019) Vol. 1, Iss. 4, pp. 329-341
Open Access | Times Cited: 138

Showing 1-25 of 138 citing articles:

Advancing the global public health agenda for NAFLD: a consensus statement
Jeffrey V. Lazarus, Henry E. Mark, Quentin M. Anstee, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 19, Iss. 1, pp. 60-78
Open Access | Times Cited: 516
Non-alcoholic fatty liver disease: A patient guideline
Sven Francque, Giulio Marchesini, Achim Kautz, et al.
JHEP Reports (2021) Vol. 3, Iss. 5, pp. 100322-100322
Open Access | Times Cited: 205
The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?
Jeffrey V. Lazarus, Henry E. Mark, Marcela Villota‐Rivas, et al.
Journal of Hepatology (2021) Vol. 76, Iss. 4, pp. 771-780
Open Access | Times Cited: 188
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?
Ramy Younes, Olivier Govaere, Salvatore Petta, et al.
Gut (2021) Vol. 71, Iss. 2, pp. 382-390
Open Access | Times Cited: 165
Metabolic drivers of non-alcoholic fatty liver disease
Kendra K. Bence, Morris J. Birnbaum
Molecular Metabolism (2020) Vol. 50, pp. 101143-101143
Open Access | Times Cited: 154
Macrophage functional diversity in NAFLD — more than inflammation
Emelie Barreby, Ping Chen, Myriam Aouadi
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 8, pp. 461-472
Closed Access | Times Cited: 151
Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review
Bertrand Cariou, Christopher D. Byrne, Rohit Loomba, et al.
Diabetes Obesity and Metabolism (2021) Vol. 23, Iss. 5, pp. 1069-1083
Open Access | Times Cited: 143
Defining comprehensive models of care for NAFLD
Jeffrey V. Lazarus, Quentin M. Anstee, Hannes Hagström, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 10, pp. 717-729
Closed Access | Times Cited: 104
A researcher’s guide to preclinical mouse NASH models
Suchira Gallage, Jose Efren Barragan Avila, Pierluigi Ramadori, et al.
Nature Metabolism (2022) Vol. 4, Iss. 12, pp. 1632-1649
Closed Access | Times Cited: 101
Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysis
Ansel Shao Pin Tang, Cheng Han Ng, Poh Hui Phang, et al.
Clinical Gastroenterology and Hepatology (2022) Vol. 21, Iss. 7, pp. 1750-1760.e12
Closed Access | Times Cited: 76
MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives
Mette Yde Hochreuter, Morten Dall, Jonas T. Treebak, et al.
Molecular Metabolism (2022) Vol. 65, pp. 101581-101581
Open Access | Times Cited: 76
Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approach
Paul Brennan, Ahmed M. Elsharkawy, Timothy J. Kendall, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 10, pp. 679-688
Open Access | Times Cited: 47
Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease
Diwakar Suresh, Akshatha N. Srinivas, Divya P. Kumar
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 126
A clinical overview of non‐alcoholic fatty liver disease: A guide to diagnosis, the clinical features, and complications—What the non‐specialist needs to know
Mark Muthiah, Ng Cheng Han, Arun J. Sanyal
Diabetes Obesity and Metabolism (2021) Vol. 24, Iss. S2, pp. 3-14
Open Access | Times Cited: 82
Lean NAFLD: an underrecognized and challenging disorder in medicine
Sheila Maier, Amanda Wieland, Melanie Cree‐Green, et al.
Reviews in Endocrine and Metabolic Disorders (2021) Vol. 22, Iss. 2, pp. 351-366
Open Access | Times Cited: 58
Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals
Chiara Saponaro, Silvia Sabatini, Melania Gaggini, et al.
Liver International (2022) Vol. 42, Iss. 11, pp. 2418-2427
Open Access | Times Cited: 58
Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
Yuna Kim, Eugene Han, Jae Seung Lee, et al.
Gut and Liver (2021) Vol. 16, Iss. 2, pp. 290-299
Open Access | Times Cited: 57
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)
Ajay Duseja, Shivaram Prasad Singh, Arka De, et al.
Journal of Clinical and Experimental Hepatology (2022) Vol. 13, Iss. 2, pp. 273-302
Open Access | Times Cited: 47
NAFLD in normal weight individuals
Johanna K. DiStefano, Glenn S. Gerhard
Diabetology & Metabolic Syndrome (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 39
Mechanisms Linking Metabolic-Associated Fatty Liver Disease (MAFLD) to Cardiovascular Disease
Olufunto O. Badmus, Terry D. Hinds, David E. Stec
Current Hypertension Reports (2023) Vol. 25, Iss. 8, pp. 151-162
Open Access | Times Cited: 38
Higher mortality among lean patients with non‐alcoholic fatty liver disease despite fewer metabolic comorbidities
Karn Wijarnpreecha, Fang Li, Sori Kim Lundin, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 57, Iss. 9, pp. 1014-1027
Open Access | Times Cited: 37
Cardiovascular morbidity and mortality in lean vs. non-lean MASLD: A comprehensive meta-analysis
Nso Nso, Damla Mergen, Mashaal Ikram, et al.
Current Problems in Cardiology (2024) Vol. 49, Iss. 6, pp. 102569-102569
Closed Access | Times Cited: 12
Non-Pharmacological Approach to Diet and Exercise in Metabolic-Associated Fatty Liver Disease: Bridging the Gap between Research and Clinical Practice
Hassam Ali, Muhammad Shahzil, Vishali Moond, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 1, pp. 61-61
Open Access | Times Cited: 10
Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study
Eunice Tan, Jonathan Lee, Nur Halisah Binte Jumat, et al.
Metabolism (2021) Vol. 126, pp. 154911-154911
Open Access | Times Cited: 46
Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactions
Jack Leslie, Daniel Geh, Ahmed M. Elsharkawy, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 1, pp. 219-236
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top